胞外囊泡
细胞外小泡
化学
生物
食品科学
生物化学
细胞生物学
微泡
基因
小RNA
作者
Sabrina Picciotto,D. V. Belmonte,Paola Gargano,Giorgia Adamo,Angela Paterna,Estella Rao,Thomas J. Conlon,Samuele Raccosta,Daniele P. Romancino,Giulia Smeraldi,Monica Salamone,Nicolas Touzet,Mauro Manno,Antonella Bongiovanni
标识
DOI:10.1016/j.jbiotec.2025.07.016
摘要
Extracellular vesicles (EVs) are lipid-based nanoparticles with strong potential as therapeutic nanocarriers, but their clinical use is limited by production and cost challenges, especially from human cells. Microalgae-derived EVs (i.e., nanoalgosomes) offer a sustainable and scalable alternative. In this study, we optimized nanoalgosome production by implementing batch-refeed systems that simulate perfusion conditions to improve microalgal viability by maintaining nutrient levels and reducing toxic metabolites. Compared to standard batch cultures, the batch-refeed strategy yielded ten-fold fewer particles but achieved 1.4-fold higher total EV protein yield, likely reflecting a reduction in non-EV co-isolates in favor of bona fide EVs. This is supported by the results of EV-associated luminal esterase activity and by the increase in membrane-enclosed EVs - detected by fluorescent nanoparticle tracking analysis - in batch-refeed-derived nanoalgosomes compared to standard batch cultures, which suggests that the batch-refeed strategy enhances their functional integrity, possibly by preserving vesicle membrane stability and reducing non-vesicular co-isolates. Furthermore, the batch-refeed strategy achieved a three-fold increase in space-time yield (STY) over conventional batch systems. Nanoalgosomes retained key functional properties post-harvest. In vitro assays confirmed that nanoalgosomes derived from both cultivation methods exhibited similar cytoprotective effects, reducing oxidative stress-induced damage in normal mammary epithelial 1-7 HB2 cells and in MDA-MB-231 breast cancer cells. These findings support the use of microalgae-based perfusion-inspired systems as a green, cost-effective and scalable strategy for producing high-quality EVs for biomedical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI